TLR4 and lung adenocarcinoma: Knockdown of KDM3A in normally active TLR4 lung adenocarcinoma cells reduces Foxp3 expression and downstream cytokines such as TGF-β1 and interleukin-35 (IL-35), as well as heme oxygenase 1.